Clinical Trial Update: Rivaroxaban in Type 2 Myocardial Infarctions [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates for rivaroxaban in Type II myocardial infarction across Phase 2 and Phase 3 have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Ii Myocardial Infarction

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: University of Alberta | Conditions: Type II Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED